Skip to main content

Animations

MJFF Publications

111 - 120 of 6295 Results
Title
Year
  • Year
  • 2014
  • 2018
  • 2013
  • 2014
  • 2011
  • 2010
  • 2009
  • 2017
  • 2017
  • 2007
  • Summary Details
    OPEN
    Title: Higher Frequency of Certain Cancers inLRRK2G2019S Mutation Carriers With Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.1973
    Citation Count: 91
  • Summary Details
    OPEN
    Title: Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/15548627.2018.1461294
    Citation Count: 121
  • Summary Details
    OPEN
    Title: Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/srep01393
    Citation Count: 150
  • Summary Details
    OPEN
    Title: Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awu057
    Citation Count: 220
  • Summary Details
    OPEN
    Title: GFAP mutations, age at onset, and clinical subtypes in Alexander disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182309f72
    Citation Count: 230
  • Summary Details
    OPEN
    Title: Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 Vectors
    Journal Name: Molecular Therapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/mt.2010.114
    Citation Count: 80
  • Summary Details
    OPEN
    Title: Subventricular zone neural progenitors from rapid brain autopsies of elderly subjects with and without neurodegenerative disease
    Journal Name: Journal of Comparative Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/cne.22040
    Citation Count: 55
  • Summary Details
    OPEN
    Title: LRRK2 levels in immune cells are increased in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-017-0010-8
    Citation Count: 237
  • Summary Details
    OPEN
    Title: Phosphorylation of LAMP2A by p38 MAPK couples ER stress to chaperone-mediated autophagy
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-017-01609-x
    Citation Count: 125
  • Summary Details
    OPEN
    Title: Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0704908104
    Citation Count: 416
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.